COA included with every order For laboratory research use only
HPLC Verified≥98% purity confirmed per lot
COA IncludedLot-specific certificate ships with order
Mass Spec IDMolecular identity confirmed per batch
USA OperationsVerified sourcing. Documented chain.
About This Compound
What Is Retatrutide 30mg?
Retatrutide is a synthetic peptide triple agonist targeting three receptors simultaneously: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. Developed by Eli Lilly, it represents the most comprehensive incretin pharmacology in a single compound — adding glucagon receptor agonism to the dual incretin approach pioneered by Tirzepatide.
In preclinical and early clinical research, Retatrutide is studied for its ability to stimulate all three metabolic hormone pathways simultaneously, enabling investigation of glucagon’s role in energy expenditure alongside GIP and GLP-1 incretin effects. The 30mg format is suitable for labs requiring higher volumes across extended research protocols.
CoreVionRX doesn’t manufacture peptides. What we do — rigorously — is verify every batch before it reaches our catalog.
≥98%
Purity by Reversed-Phase HPLC
HPLC separates the compound from any impurities and measures the exact purity percentage. The chromatogram is documented on your COA.
MS/MS
Mass Spectrometry Identity Check
Electrospray ionization mass spectrometry verifies the molecular weight matches the compound specification. Confirms you’re getting the actual compound.
Lot #
Lot-Specific Certificate of Analysis
Your COA is tied to your specific production lot — not a generic document. This is not standard practice in this market. We made it one anyway.
100%
Documented Before Listing
No compound reaches our catalog without clearing our verification process first. If documentation isn’t available for a batch, that batch doesn’t ship.
Technical Specifications
Full Product Data
Everything you need to evaluate this compound for your research protocol.
Confirmed by electrospray ionization mass spectrometry
Storage (lyophilized)
−20°C, protected from light and moisture
Storage (reconstituted)
2–8°C, away from light
Documentation
Lot-specific COA with HPLC chromatogram — included with every order
Preclinical Research
What Researchers Study Retatrutide 30mg For
All published research is preclinical — cell cultures and animal models. No human clinical trial data exists for Retatrutide 30mg. Here’s where the science currently stands.
Triple Receptor Agonism Research
Retatrutide enables simultaneous investigation of GIP, GLP-1, and glucagon receptor pharmacology. Research examines how triple co-agonism produces outcomes distinct from dual (Tirzepatide) or single (semaglutide) agonists.
Jastreboff AM. et al. (2023) N Engl J Med 389(6):514-26
Glucagon Receptor Pathway Studies
The addition of glucagon receptor agonism to GIP/GLP-1 activity is Retatrutide’s defining research feature. Studies examine glucagon’s role in hepatic glucose production, energy expenditure, and lipolysis when activated alongside incretin pathways.
Samms RJ. et al. (2023) Cell Metab 35(9):1517-33
Comparative Incretin Biology
Retatrutide is a valuable pharmacological tool for understanding incretin hierarchy — comparing the contributions of GIP, GLP-1, and glucagon to metabolic regulation, both individually and in combination.
Coskun T. et al. (2022) Mol Metab 66:101634
Why CoreVionRX
Documentation Is the Product.
Most peptide vendors claim purity. We document it. Every compound ships with independent lab verification — not because regulations require it, but because you deserve to know exactly what you’re working with.
Independent HPLC Testing
Every batch runs through reversed-phase HPLC before we list it. The chromatogram appears on your COA. Verify the peak profile yourself.
Lot-Specific Documentation
Your COA is tied to your production lot — not a template document. “COA available upon request” is not how we operate.
Transparent About What We Are
We source and verify. We are not a synthesis lab. That honesty is deliberate — it’s the only way to build a brand worth buying from twice.
Lyophilized for Stability
Ships as lyophilized powder — stable at −20°C for 24+ months. Full integrity maintained until you’re ready to reconstitute.
Common Questions
Straight Answers.
What is Retatrutide and how does it differ from Tirzepatide?
Retatrutide is a triple receptor agonist — it activates GIP, GLP-1, and glucagon receptors simultaneously. Tirzepatide is a dual agonist (GIP + GLP-1 only). Retatrutide adds glucagon receptor agonism, which plays a distinct role in hepatic glucose production and energy expenditure research.
What is GLP-3RT?
GLP-3RT is CoreVionRX’s catalog designation for Retatrutide — the triple GLP receptor compound. The three target receptors are the GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GcgR).
What research areas use Retatrutide?
Research focuses on triple incretin receptor pharmacology, comparative metabolic biology (vs Tirzepatide and GLP-1 agonists), hepatic glucose regulation, energy expenditure pathways, and adipose tissue biology. Clinical phase trial data has been published, making it relevant for translational research.
How do I reconstitute Retatrutide?
Reconstitute with bacteriostatic water. Inject water slowly down the vial wall, swirl gently. Use our reconstitution calculator for exact volumes based on your target concentration and experimental design.
How should Retatrutide be stored?
Store lyophilized at −20°C, protected from light and moisture. After reconstitution, store at 2–8°C away from light. The 30mg format suits labs running multi-experiment protocols with larger volume requirements.
For laboratory research use only. Not for human or animal consumption. CoreVionRX supplies research compounds to qualified laboratories and research institutions.
Retatrutide 30mg Research Peptide: What to Know Before You Buy
retatrutide 30mg research peptide from CoreVionRX is verified at ≥99%% HPLC purity with mass spectrometry confirming the exact peptide sequence.
Every retatrutide 30mg research peptide vial ships with HPLC verification and a lot-specific COA.
Every vial of retatrutide 30mg research peptide ships with a lot-specific certificate of analysis so you can verify exactly what is in the vial you received.
CoreVionRX retatrutide 30mg research peptide is verified by independent third-party testing — mass spectrometry confirms sequence identity and HPLC confirms purity.
Store retatrutide 30mg research peptide as a lyophilized powder in cool, dark conditions; once reconstituted, keep refrigerated and use within your protocol window.
For accurate reconstitution of retatrutide 30mg research peptide, use the peptide calculator to calculate the exact water volume needed.
Researchers working with retatrutide 30mg research peptide should confirm ≥99%% HPLC purity and a lot-specific COA with every order.
For reconstitution, add bacteriostatic water slowly and store retatrutide 30mg research peptide refrigerated after mixing. Use the peptide calculator to get concentration right.
When sourcing retatrutide 30mg research peptide, the most important check is purity: every CoreVionRX vial is verified at ≥99% HPLC with a lot-specific COA.
Peer-reviewed research on retatrutide 30mg research peptide is indexed at PubMed. For research use only.
All CoreVionRX research peptides ship with a lot-specific COA, ≥99%% HPLC purity, and mass-spec identity confirmation. Use our reconstitution calculator for prep. For research use only.
Sourcing verified retatrutide 30mg research peptide is the first step in any reliable research protocol.
